HRP970415A2 - Substituted pyrroles - Google Patents
Substituted pyrroles Download PDFInfo
- Publication number
- HRP970415A2 HRP970415A2 HR60/048,496A HRP970415A HRP970415A2 HR P970415 A2 HRP970415 A2 HR P970415A2 HR P970415 A HRP970415 A HR P970415A HR P970415 A2 HRP970415 A2 HR P970415A2
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- indol
- compound according
- pyrrole
- alkyl
- Prior art date
Links
- 150000003233 pyrroles Chemical class 0.000 title description 6
- 150000001875 compounds Chemical class 0.000 claims description 90
- 125000000217 alkyl group Chemical group 0.000 claims description 59
- 229910052739 hydrogen Inorganic materials 0.000 claims description 35
- 239000001257 hydrogen Substances 0.000 claims description 32
- -1 nitro, amino Chemical group 0.000 claims description 26
- 229910052736 halogen Inorganic materials 0.000 claims description 22
- 150000002367 halogens Chemical class 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 20
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 19
- 125000004414 alkyl thio group Chemical group 0.000 claims description 16
- 125000004442 acylamino group Chemical group 0.000 claims description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 14
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 125000001188 haloalkyl group Chemical group 0.000 claims description 9
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 150000007513 acids Chemical class 0.000 claims description 7
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 7
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims description 6
- 125000004104 aryloxy group Chemical group 0.000 claims description 6
- 150000001540 azides Chemical class 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 150000007514 bases Chemical class 0.000 claims description 5
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 5
- DHHHPVHEKHYOEU-UHFFFAOYSA-N 3,4-bis(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical group COC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 DHHHPVHEKHYOEU-UHFFFAOYSA-N 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- 239000000651 prodrug Substances 0.000 claims description 4
- 229940002612 prodrug Drugs 0.000 claims description 4
- NEMOFKXFUODUAQ-UHFFFAOYSA-N 3,4-bis(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical group C12=CC=C([N+]([O-])=O)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O NEMOFKXFUODUAQ-UHFFFAOYSA-N 0.000 claims description 3
- ZTRMHGRYYSKSQX-UHFFFAOYSA-N 3-(1,6-dimethylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C)=CN(C)C2=C1 ZTRMHGRYYSKSQX-UHFFFAOYSA-N 0.000 claims description 3
- VYRZEYSNPOXGFE-UHFFFAOYSA-N 3-[4-(6-amino-1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindole-6-carbonitrile Chemical compound C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)C#N)C(=O)NC1=O VYRZEYSNPOXGFE-UHFFFAOYSA-N 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- DENNIJDJQGTSQS-UHFFFAOYSA-N 3-(2-amino-1,6-dimethylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound CC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=C(N)N(C)C2=C1 DENNIJDJQGTSQS-UHFFFAOYSA-N 0.000 claims description 2
- RYAUTVHKOZZQRF-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(1,6-dimethylindol-3-yl)pyrrole-2,5-dione Chemical compound NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C)=CN(C)C2=C1 RYAUTVHKOZZQRF-UHFFFAOYSA-N 0.000 claims description 2
- AOBBETHIFSZWRG-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(6-bromo-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(Br)C=C3N(C)C=2)C(=O)NC1=O AOBBETHIFSZWRG-UHFFFAOYSA-N 0.000 claims description 2
- 230000004663 cell proliferation Effects 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 6
- OUCNDEVWCWRBQK-UHFFFAOYSA-N 3-[4-(1,6-dimethylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindole-6-carbonitrile Chemical compound N#CC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C)=CN(C)C2=C1 OUCNDEVWCWRBQK-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 49
- 230000008018 melting Effects 0.000 description 44
- 238000002844 melting Methods 0.000 description 44
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 36
- 239000000243 solution Substances 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 239000000203 mixture Substances 0.000 description 29
- 238000000034 method Methods 0.000 description 27
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- FWRAEYXMASVQTF-UHFFFAOYSA-N propan-2-yl 2-(1-methyl-6-nitroindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.[O-][N+](=O)C1=CC=C2C(CC(=N)OC(C)C)=CN(C)C2=C1 FWRAEYXMASVQTF-UHFFFAOYSA-N 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 17
- 235000019439 ethyl acetate Nutrition 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 15
- 235000019341 magnesium sulphate Nutrition 0.000 description 15
- 239000002904 solvent Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 125000001424 substituent group Chemical group 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- 239000007787 solid Substances 0.000 description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 8
- UHXUUGXBVISQOH-UHFFFAOYSA-N propan-2-yl 2-(5-methoxy-1-methylindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.COC1=CC=C2N(C)C=C(CC(=N)OC(C)C)C2=C1 UHXUUGXBVISQOH-UHFFFAOYSA-N 0.000 description 8
- NXSKAFXOBAPOFO-UHFFFAOYSA-N propan-2-yl 2-(6-methoxy-1-methylindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.COC1=CC=C2C(CC(=N)OC(C)C)=CN(C)C2=C1 NXSKAFXOBAPOFO-UHFFFAOYSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000004440 column chromatography Methods 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- VTERTDXYBJGLGB-UHFFFAOYSA-N 2-(1-methyl-6-nitroindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C([N+]([O-])=O)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 VTERTDXYBJGLGB-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- RCMUCJKZDTYCCT-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 RCMUCJKZDTYCCT-UHFFFAOYSA-N 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- WEFXNTLSKCMIME-UHFFFAOYSA-N 2-(6-cyano-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(C#N)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 WEFXNTLSKCMIME-UHFFFAOYSA-N 0.000 description 4
- VATAIYAPPIYGCK-UHFFFAOYSA-N 3,4-bis(6-amino-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(N)C=C3N(C)C=2)C(=O)NC1=O VATAIYAPPIYGCK-UHFFFAOYSA-N 0.000 description 4
- AFNRHTISODTULX-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(6-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(F)C=C3N(C)C=2)C(=O)NC1=O AFNRHTISODTULX-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- HRVHQTVGRQVNKW-UHFFFAOYSA-N propan-2-yl 2-(1,6-dimethylindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.CC1=CC=C2C(CC(=N)OC(C)C)=CN(C)C2=C1 HRVHQTVGRQVNKW-UHFFFAOYSA-N 0.000 description 4
- CFOAUYCPAUGDFF-UHFFFAOYSA-N tosmic Chemical compound CC1=CC=C(S(=O)(=O)C[N+]#[C-])C=C1 CFOAUYCPAUGDFF-UHFFFAOYSA-N 0.000 description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 3
- XDZKJWVLSJKLST-UHFFFAOYSA-N 1-amino-3,4-bis(1h-indol-2-yl)pyrrole-2,5-dione Chemical compound C1=CC=C2NC(C=3C(=O)N(C(C=3C=3NC4=CC=CC=C4C=3)=O)N)=CC2=C1 XDZKJWVLSJKLST-UHFFFAOYSA-N 0.000 description 3
- AYGFFYXMDIOSFO-UHFFFAOYSA-N 1-methyl-6-nitroindole Chemical compound C1=C([N+]([O-])=O)C=C2N(C)C=CC2=C1 AYGFFYXMDIOSFO-UHFFFAOYSA-N 0.000 description 3
- OOHMTPJLHLKWLK-UHFFFAOYSA-N 2-(1-methyl-6-methylsulfanylindol-3-yl)-2-oxoacetyl chloride Chemical compound CSC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 OOHMTPJLHLKWLK-UHFFFAOYSA-N 0.000 description 3
- SHAGXXOFOOLLBH-UHFFFAOYSA-N 2-(4-fluoro-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1F SHAGXXOFOOLLBH-UHFFFAOYSA-N 0.000 description 3
- MBMZNVBRAUARDX-UHFFFAOYSA-N 2-(4-methoxy-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound COC1=CC=CC2=C1C(C(=O)C(Cl)=O)=CN2C MBMZNVBRAUARDX-UHFFFAOYSA-N 0.000 description 3
- VOARXEAVUAYRLE-UHFFFAOYSA-N 2-(5-cyano-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound N#CC1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 VOARXEAVUAYRLE-UHFFFAOYSA-N 0.000 description 3
- MOVWHUCLGMYFRJ-UHFFFAOYSA-N 2-(6-chloro-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(Cl)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 MOVWHUCLGMYFRJ-UHFFFAOYSA-N 0.000 description 3
- LSMNIAWTHOCTKL-UHFFFAOYSA-N 2-(6-fluoro-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(F)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 LSMNIAWTHOCTKL-UHFFFAOYSA-N 0.000 description 3
- GEGLYQYECJWJNL-UHFFFAOYSA-N 3-(6-methoxy-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 GEGLYQYECJWJNL-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 150000003840 hydrochlorides Chemical class 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- WHSLZNPKTFSMHP-UHFFFAOYSA-N n-[1-methyl-3-[4-(1-methyl-6-nitroindol-3-yl)-2,5-dioxopyrrol-3-yl]-2h-indol-3-yl]acetamide Chemical compound C12=CC=CC=C2N(C)CC1(NC(C)=O)C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O WHSLZNPKTFSMHP-UHFFFAOYSA-N 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- DZXIYFTZNCKWLG-UHFFFAOYSA-N 1-methyl-3-[4-(1-methyl-6-nitroindol-3-yl)-2,5-dioxopyrrol-3-yl]indole-6-carbonitrile Chemical compound C12=CC=C(C#N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O DZXIYFTZNCKWLG-UHFFFAOYSA-N 0.000 description 2
- NKDOUVHMIPLZFP-UHFFFAOYSA-N 1-methylindol-6-amine;hydrochloride Chemical compound Cl.C1=C(N)C=C2N(C)C=CC2=C1 NKDOUVHMIPLZFP-UHFFFAOYSA-N 0.000 description 2
- MIMYTSWNVBMNRH-UHFFFAOYSA-N 1h-indol-6-amine Chemical compound NC1=CC=C2C=CNC2=C1 MIMYTSWNVBMNRH-UHFFFAOYSA-N 0.000 description 2
- WBYHCAAPHDLMGA-UHFFFAOYSA-N 2,2,2-trifluoro-n-(1-methylindol-6-yl)acetamide Chemical compound C1=C(NC(=O)C(F)(F)F)C=C2N(C)C=CC2=C1 WBYHCAAPHDLMGA-UHFFFAOYSA-N 0.000 description 2
- LGVGGGFVASYZIB-UHFFFAOYSA-N 2-(1,5-dimethylindol-3-yl)-2-oxoacetyl chloride Chemical compound CC1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 LGVGGGFVASYZIB-UHFFFAOYSA-N 0.000 description 2
- QBQCDHCCEVMSHU-UHFFFAOYSA-N 2-(5-chloro-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound ClC1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 QBQCDHCCEVMSHU-UHFFFAOYSA-N 0.000 description 2
- FMDDEAHFVZRKNJ-UHFFFAOYSA-N 2-(6-acetamido-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound CC(=O)NC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 FMDDEAHFVZRKNJ-UHFFFAOYSA-N 0.000 description 2
- YIGVDZAHSTVYDX-UHFFFAOYSA-N 2-(6-methoxy-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound COC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 YIGVDZAHSTVYDX-UHFFFAOYSA-N 0.000 description 2
- LNUOZWIFGAJCAE-UHFFFAOYSA-N 2-(6-methoxy-1-methylindol-3-yl)acetonitrile Chemical compound COC1=CC=C2C(CC#N)=CN(C)C2=C1 LNUOZWIFGAJCAE-UHFFFAOYSA-N 0.000 description 2
- KZLVMCGDHNDZEL-UHFFFAOYSA-N 2-[1-methyl-6-[(2,2,2-trifluoroacetyl)amino]indol-3-yl]-2-oxoacetyl chloride Chemical compound C1=C(NC(=O)C(F)(F)F)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 KZLVMCGDHNDZEL-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- GTVGZOSMUXVPFP-UHFFFAOYSA-N 3-(1-methyl-6-methylsulfanylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)SC)=CN(C)C2=C1 GTVGZOSMUXVPFP-UHFFFAOYSA-N 0.000 description 2
- LQPLRMXMQHNLET-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O LQPLRMXMQHNLET-UHFFFAOYSA-N 0.000 description 2
- SBPZYAQZZMYISB-UHFFFAOYSA-N 3-(6-bromo-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(Br)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O SBPZYAQZZMYISB-UHFFFAOYSA-N 0.000 description 2
- AQOALQIVYNLHDJ-UHFFFAOYSA-N 3-(6-fluoro-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(F)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O AQOALQIVYNLHDJ-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- WRHNJAIUBFJMEM-UHFFFAOYSA-N 6-methoxy-1-methylindole-3-carbaldehyde Chemical compound COC1=CC=C2C(C=O)=CN(C)C2=C1 WRHNJAIUBFJMEM-UHFFFAOYSA-N 0.000 description 2
- QJRWYBIKLXNYLF-UHFFFAOYSA-N 6-methoxy-1h-indole Chemical compound COC1=CC=C2C=CNC2=C1 QJRWYBIKLXNYLF-UHFFFAOYSA-N 0.000 description 2
- JTEFJNIWWXTBMP-UHFFFAOYSA-N 6-methoxy-1h-indole-3-carbaldehyde Chemical compound COC1=CC=C2C(C=O)=CNC2=C1 JTEFJNIWWXTBMP-UHFFFAOYSA-N 0.000 description 2
- PSWCIARYGITEOY-UHFFFAOYSA-N 6-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2C=CNC2=C1 PSWCIARYGITEOY-UHFFFAOYSA-N 0.000 description 2
- DQYBRTASHMYDJG-UHFFFAOYSA-N Bisindolylmaleimide Chemical compound C1=CC=C2C(C=3C(=O)NC(C=3C=3C4=CC=CC=C4NC=3)=O)=CNC2=C1 DQYBRTASHMYDJG-UHFFFAOYSA-N 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 229910019213 POCl3 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004103 aminoalkyl group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SFAXSGRMHPVGMG-UHFFFAOYSA-N benzyl n-[3-[4-(6-methoxy-1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindol-6-yl]-n-methylcarbamate Chemical compound C=1N(C)C2=CC(OC)=CC=C2C=1C(C(NC1=O)=O)=C1C(C1=CC=2)=CN(C)C1=CC=2N(C)C(=O)OCC1=CC=CC=C1 SFAXSGRMHPVGMG-UHFFFAOYSA-N 0.000 description 2
- GFPULFXOWRWEDL-UHFFFAOYSA-N benzyl n-methyl-n-(1-methylindol-6-yl)carbamate Chemical compound C=1C=C2C=CN(C)C2=CC=1N(C)C(=O)OCC1=CC=CC=C1 GFPULFXOWRWEDL-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 150000004292 cyclic ethers Chemical class 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- 229910052987 metal hydride Inorganic materials 0.000 description 2
- 150000004681 metal hydrides Chemical class 0.000 description 2
- YWHJNIAFMIGSHV-UHFFFAOYSA-N methyl 2-azido-3-(4-methylsulfanylphenyl)prop-2-enoate Chemical compound COC(=O)C(N=[N+]=[N-])=CC1=CC=C(SC)C=C1 YWHJNIAFMIGSHV-UHFFFAOYSA-N 0.000 description 2
- WIDPUEXDDQAFTO-UHFFFAOYSA-N methyl 6-methylsulfanyl-1h-indole-2-carboxylate Chemical compound C1=C(SC)C=C2NC(C(=O)OC)=CC2=C1 WIDPUEXDDQAFTO-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- UPOQSRSOENMVDY-UHFFFAOYSA-N n,1-dimethylindol-6-amine Chemical compound CNC1=CC=C2C=CN(C)C2=C1 UPOQSRSOENMVDY-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- KPGSSDDOYJGQBY-UHFFFAOYSA-N propan-2-yl 2-(1-methyl-7-nitroindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.C1=CC=C2C(CC(=N)OC(C)C)=CN(C)C2=C1[N+]([O-])=O KPGSSDDOYJGQBY-UHFFFAOYSA-N 0.000 description 2
- MJEXPQIFDCDILO-UHFFFAOYSA-N propan-2-yl 2-(6-ethoxy-1-methylindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.CCOC1=CC=C2C(CC(=N)OC(C)C)=CN(C)C2=C1 MJEXPQIFDCDILO-UHFFFAOYSA-N 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000004001 thioalkyl group Chemical group 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- MTZOSTDWLSSPHA-UHFFFAOYSA-N 1-methylindol-6-amine Chemical compound C1=C(N)C=C2N(C)C=CC2=C1 MTZOSTDWLSSPHA-UHFFFAOYSA-N 0.000 description 1
- RSUCXQRUMFUPLX-UHFFFAOYSA-N 2-(1,6-dimethylindol-3-yl)-2-oxoacetyl chloride Chemical compound CC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 RSUCXQRUMFUPLX-UHFFFAOYSA-N 0.000 description 1
- QQHAARBQMLVNFA-UHFFFAOYSA-N 2-(1-methyl-5-nitroindol-3-yl)-2-oxoacetyl chloride Chemical compound [O-][N+](=O)C1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 QQHAARBQMLVNFA-UHFFFAOYSA-N 0.000 description 1
- KSXPVMSAYPBSAW-UHFFFAOYSA-N 2-(1-methyl-6-nitroindol-3-yl)acetonitrile Chemical compound C1=C([N+]([O-])=O)C=C2N(C)C=C(CC#N)C2=C1 KSXPVMSAYPBSAW-UHFFFAOYSA-N 0.000 description 1
- ITHUAPWEWPAESE-UHFFFAOYSA-N 2-(1-methyl-6-phenylmethoxyindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C2N(C)C=C(C(=O)C(Cl)=O)C2=CC=C1OCC1=CC=CC=C1 ITHUAPWEWPAESE-UHFFFAOYSA-N 0.000 description 1
- ADURISYFQJCUOT-UHFFFAOYSA-N 2-(1-methyl-7-nitroindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=CC([N+]([O-])=O)=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 ADURISYFQJCUOT-UHFFFAOYSA-N 0.000 description 1
- AODCYPBWNCZMLE-UHFFFAOYSA-N 2-(4-bromo-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1Br AODCYPBWNCZMLE-UHFFFAOYSA-N 0.000 description 1
- ZJUGTCYOQGGMJF-UHFFFAOYSA-N 2-(5-methoxy-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound COC1=CC=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 ZJUGTCYOQGGMJF-UHFFFAOYSA-N 0.000 description 1
- OYAVWZCFDJYNFB-UHFFFAOYSA-N 2-(6-azido-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(N=[N+]=[N-])C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 OYAVWZCFDJYNFB-UHFFFAOYSA-N 0.000 description 1
- HLJRRGNEADQPHK-UHFFFAOYSA-N 2-(6-bromo-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(Br)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 HLJRRGNEADQPHK-UHFFFAOYSA-N 0.000 description 1
- GHDQKPBSEZCOJO-UHFFFAOYSA-N 2-(6-ethoxy-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound CCOC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 GHDQKPBSEZCOJO-UHFFFAOYSA-N 0.000 description 1
- DMGKWTXFINJXSA-UHFFFAOYSA-N 2-(6-iodo-1-methylindol-3-yl)-2-oxoacetyl chloride Chemical compound C1=C(I)C=C2N(C)C=C(C(=O)C(Cl)=O)C2=C1 DMGKWTXFINJXSA-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- CTYUARXJJSGJJU-UHFFFAOYSA-N 2-[6-[2-(2-ethoxyethoxy)ethoxy]-1-methylindol-3-yl]-2-oxoacetyl chloride Chemical compound CCOCCOCCOC1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 CTYUARXJJSGJJU-UHFFFAOYSA-N 0.000 description 1
- WPZQPDYNVHHVDB-UHFFFAOYSA-N 3,4-bis(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C(OC)C=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 WPZQPDYNVHHVDB-UHFFFAOYSA-N 0.000 description 1
- SOZPHISDUAAINE-UHFFFAOYSA-N 3-(1,5-dimethylindol-3-yl)-4-(1,6-dimethylindol-3-yl)pyrrole-2,5-dione Chemical compound CC1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)C)=CN(C)C2=C1 SOZPHISDUAAINE-UHFFFAOYSA-N 0.000 description 1
- OHEWYFFHYUZBGO-UHFFFAOYSA-N 3-(1,5-dimethylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C(C)C=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 OHEWYFFHYUZBGO-UHFFFAOYSA-N 0.000 description 1
- DOGRYVZSPFUSLJ-UHFFFAOYSA-N 3-(1,6-dimethylindol-3-yl)-4-(1-methyl-7-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C)=CN(C)C2=C1[N+]([O-])=O DOGRYVZSPFUSLJ-UHFFFAOYSA-N 0.000 description 1
- AEUOPGMQEZUHRH-UHFFFAOYSA-N 3-(1-methyl-5-nitroindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O AEUOPGMQEZUHRH-UHFFFAOYSA-N 0.000 description 1
- AUHXDRWVPXMGPO-UHFFFAOYSA-N 3-(1-methyl-6-nitroindol-3-yl)-4-(1-methyl-6-phenylmethoxyindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C2N(C)C=C(C=3C(NC(=O)C=3C=3C4=CC=C(C=C4N(C)C=3)[N+]([O-])=O)=O)C2=CC=C1OCC1=CC=CC=C1 AUHXDRWVPXMGPO-UHFFFAOYSA-N 0.000 description 1
- BCPLCKLBFNZFHF-UHFFFAOYSA-N 3-(1-methyl-6-nitroindol-3-yl)-4-(1-methyl-7-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C([N+]([O-])=O)C=C2N(C)C=C1C1=C(C=2C3=CC=CC(=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O BCPLCKLBFNZFHF-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- IALHCIPMPHGBEF-UHFFFAOYSA-N 3-(4-bromo-1-methylindol-3-yl)-4-(6-ethoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(Br)=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCC)=CN(C)C2=C1 IALHCIPMPHGBEF-UHFFFAOYSA-N 0.000 description 1
- LECJABKVHGIYHA-UHFFFAOYSA-N 3-(4-fluoro-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C([N+]([O-])=O)C=C2N(C)C=C1C1=C(C=2C3=C(F)C=CC=C3N(C)C=2)C(=O)NC1=O LECJABKVHGIYHA-UHFFFAOYSA-N 0.000 description 1
- PTGHTIJBKJRRTB-UHFFFAOYSA-N 3-(4-fluoro-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(F)=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 PTGHTIJBKJRRTB-UHFFFAOYSA-N 0.000 description 1
- YCKYELGJROPRNG-UHFFFAOYSA-N 3-(4-methoxy-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C=4C=CC=C(C3=4)OC)=CN(C)C2=C1 YCKYELGJROPRNG-UHFFFAOYSA-N 0.000 description 1
- XCUQCCVOZUVKOE-UHFFFAOYSA-N 3-(4-methoxy-1-methylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(OC)=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 XCUQCCVOZUVKOE-UHFFFAOYSA-N 0.000 description 1
- RXAQTWCQDDZRRJ-UHFFFAOYSA-N 3-(4-methoxy-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(OC)=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 RXAQTWCQDDZRRJ-UHFFFAOYSA-N 0.000 description 1
- DJWRNOSBPQXHBV-UHFFFAOYSA-N 3-(5-chloro-1-methylindol-3-yl)-4-(1,6-dimethylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C(Cl)C=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C)=CN(C)C2=C1 DJWRNOSBPQXHBV-UHFFFAOYSA-N 0.000 description 1
- HIKITLLOKBXDAM-UHFFFAOYSA-N 3-(5-chloro-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC(Cl)=CC=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O HIKITLLOKBXDAM-UHFFFAOYSA-N 0.000 description 1
- SAUXAZQHVCUVPP-UHFFFAOYSA-N 3-(5-chloro-1-methylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C(Cl)C=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 SAUXAZQHVCUVPP-UHFFFAOYSA-N 0.000 description 1
- VXCFHYYVGHGICT-UHFFFAOYSA-N 3-(5-methoxy-1-methylindol-3-yl)-4-(1-methyl-6-methylsulfanylindol-3-yl)pyrrole-2,5-dione Chemical compound CSC1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 VXCFHYYVGHGICT-UHFFFAOYSA-N 0.000 description 1
- AXNISBXLGLXICC-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(6-chloro-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(Cl)C=C3N(C)C=2)C(=O)NC1=O AXNISBXLGLXICC-UHFFFAOYSA-N 0.000 description 1
- CWBGAXSULQNPCB-UHFFFAOYSA-N 3-(6-amino-1-methylindol-3-yl)-4-(6-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione;hydrochloride Chemical compound Cl.C12=CC=C(N)C=C2N(C)C=C1C1=C(C=2C3=CC=C(F)C=C3N(C)C=2)C(=O)NC1=O CWBGAXSULQNPCB-UHFFFAOYSA-N 0.000 description 1
- FJVPXGFXXFQOKE-UHFFFAOYSA-N 3-(6-azido-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound [N-]=[N+]=NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 FJVPXGFXXFQOKE-UHFFFAOYSA-N 0.000 description 1
- SKVWDCUGXXGZAA-UHFFFAOYSA-N 3-(6-chloro-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(Cl)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O SKVWDCUGXXGZAA-UHFFFAOYSA-N 0.000 description 1
- ZKSVMVQOZGPIAY-UHFFFAOYSA-N 3-(6-chloro-1-methylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound ClC1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 ZKSVMVQOZGPIAY-UHFFFAOYSA-N 0.000 description 1
- YHDSCEWSGZZSCR-UHFFFAOYSA-N 3-(6-chloro-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound ClC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 YHDSCEWSGZZSCR-UHFFFAOYSA-N 0.000 description 1
- LHLWPXGBFGNKPZ-UHFFFAOYSA-N 3-(6-ethoxy-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCC)=CN(C)C2=C1 LHLWPXGBFGNKPZ-UHFFFAOYSA-N 0.000 description 1
- ODWRMQSOHHUGFB-UHFFFAOYSA-N 3-(6-ethoxy-1-methylindol-3-yl)-4-(4-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC(F)=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCC)=CN(C)C2=C1 ODWRMQSOHHUGFB-UHFFFAOYSA-N 0.000 description 1
- KAJPXTXSWZVCAV-UHFFFAOYSA-N 3-(6-ethoxy-1-methylindol-3-yl)-4-(5-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound C1=C(OC)C=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCC)=CN(C)C2=C1 KAJPXTXSWZVCAV-UHFFFAOYSA-N 0.000 description 1
- HRXXZPQYCILUOM-UHFFFAOYSA-N 3-(6-fluoro-1-methylindol-3-yl)-4-(1-methyl-7-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(F)C=C2N(C)C=C1C1=C(C=2C3=CC=CC(=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O HRXXZPQYCILUOM-UHFFFAOYSA-N 0.000 description 1
- SIHUCQHLTHLODJ-UHFFFAOYSA-N 3-(6-fluoro-1-methylindol-3-yl)-4-(6-methoxy-1-methylindol-3-yl)pyrrole-2,5-dione Chemical compound FC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 SIHUCQHLTHLODJ-UHFFFAOYSA-N 0.000 description 1
- RMRXZZWUAIRTNF-UHFFFAOYSA-N 3-(6-iodo-1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=C(I)C=C2N(C)C=C1C1=C(C=2C3=CC=C(C=C3N(C)C=2)[N+]([O-])=O)C(=O)NC1=O RMRXZZWUAIRTNF-UHFFFAOYSA-N 0.000 description 1
- NXMFQEUMYSNXSZ-UHFFFAOYSA-N 3-[4-(5-methoxy-1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 NXMFQEUMYSNXSZ-UHFFFAOYSA-N 0.000 description 1
- LZSBOPVYAUOKQD-UHFFFAOYSA-N 3-[4-(5-methoxy-1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindole-6-carbonitrile Chemical compound N#CC1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(C)C4=CC=C(C=C43)OC)=CN(C)C2=C1 LZSBOPVYAUOKQD-UHFFFAOYSA-N 0.000 description 1
- ARABSILULFFLQS-UHFFFAOYSA-N 3-[4-(6-methoxy-1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindole-6-carbonitrile Chemical compound N#CC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 ARABSILULFFLQS-UHFFFAOYSA-N 0.000 description 1
- YFXFZEMARQTJFS-UHFFFAOYSA-N 3-[6-[2-(2-ethoxyethoxy)ethoxy]-1-methylindol-3-yl]-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OCCOCCOCC)=CN(C)C2=C1 YFXFZEMARQTJFS-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- QRVYABWJVXXOTN-UHFFFAOYSA-N 4-methylsulfanylbenzaldehyde Chemical compound CSC1=CC=C(C=O)C=C1 QRVYABWJVXXOTN-UHFFFAOYSA-N 0.000 description 1
- XBTHQAKYJGTLRT-UHFFFAOYSA-N 6-methylsulfanyl-1h-indole Chemical compound CSC1=CC=C2C=CNC2=C1 XBTHQAKYJGTLRT-UHFFFAOYSA-N 0.000 description 1
- OJPNRJVMABFYLM-UHFFFAOYSA-N 6-methylsulfanyl-1h-indole-2-carboxylic acid Chemical compound CSC1=CC=C2C=C(C(O)=O)NC2=C1 OJPNRJVMABFYLM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical class [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 150000004645 aluminates Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008190 ground granulate Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- DSOVBLHCROGBFQ-UHFFFAOYSA-N methyl 1-methyl-3-[4-(1-methyl-6-nitroindol-3-yl)-2,5-dioxopyrrol-3-yl]indole-6-carboxylate Chemical compound [O-][N+](=O)C1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)C(=O)OC)=CN(C)C2=C1 DSOVBLHCROGBFQ-UHFFFAOYSA-N 0.000 description 1
- RXYCUKSOYJWGPE-UHFFFAOYSA-N methyl 2-azidoacetate Chemical compound COC(=O)CN=[N+]=[N-] RXYCUKSOYJWGPE-UHFFFAOYSA-N 0.000 description 1
- IBPIJISCEZWTFZ-UHFFFAOYSA-N methyl 3-(2-chloro-2-oxoacetyl)-1-methylindole-6-carboxylate Chemical compound COC(=O)C1=CC=C2C(C(=O)C(Cl)=O)=CN(C)C2=C1 IBPIJISCEZWTFZ-UHFFFAOYSA-N 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- RLCGEWDRHUFTTG-UHFFFAOYSA-N n-[3-[4-(6-acetamido-1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindol-6-yl]acetamide Chemical compound CC(=O)NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)NC(=O)C)=CN(C)C2=C1 RLCGEWDRHUFTTG-UHFFFAOYSA-N 0.000 description 1
- CGHDUQIDEQEOOV-UHFFFAOYSA-N n-[3-[4-(6-methoxy-1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]-1-methylindol-6-yl]acetamide Chemical compound CC(=O)NC1=CC=C2C(C3=C(C(NC3=O)=O)C=3C4=CC=C(C=C4N(C)C=3)OC)=CN(C)C2=C1 CGHDUQIDEQEOOV-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- XTGDUUHTQKAMAP-UHFFFAOYSA-N propan-2-yl 2-(1,5-dimethylindol-3-yl)ethanimidate;hydrochloride Chemical compound Cl.C1=C(C)C=C2C(CC(=N)OC(C)C)=CN(C)C2=C1 XTGDUUHTQKAMAP-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2207896P | 1996-07-29 | 1996-07-29 | |
| US4849697P | 1997-06-03 | 1997-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP970415A2 true HRP970415A2 (en) | 1998-08-31 |
Family
ID=26695475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR60/048,496A HRP970415A2 (en) | 1996-07-29 | 1997-07-25 | Substituted pyrroles |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6228877B1 (de) |
| EP (1) | EP0915870B1 (de) |
| JP (1) | JP2000516588A (de) |
| KR (1) | KR20000029640A (de) |
| CN (1) | CN1077571C (de) |
| AR (1) | AR007969A1 (de) |
| AT (1) | ATE224889T1 (de) |
| AU (1) | AU740011B2 (de) |
| BR (1) | BR9711607A (de) |
| CA (1) | CA2262089A1 (de) |
| CO (1) | CO4900054A1 (de) |
| DE (1) | DE69715870T2 (de) |
| DK (1) | DK0915870T3 (de) |
| ES (1) | ES2183163T3 (de) |
| HR (1) | HRP970415A2 (de) |
| MA (1) | MA24354A1 (de) |
| PE (1) | PE91598A1 (de) |
| PT (1) | PT915870E (de) |
| TR (1) | TR199900186T2 (de) |
| WO (1) | WO1998004551A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS49965B (sr) * | 1998-03-17 | 2008-09-29 | F.Hoffmann-La Roche Ag., | Supstituisani bisindolmaleimidi za inhibiciju ćelijske proliferacije |
| US6350786B1 (en) | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| PL357441A1 (en) * | 1999-10-12 | 2004-07-26 | F.Hoffmann-La Roche Ag | Substituted pyrroles as antiproliferative agents for the treatment of cancer |
| US6559164B1 (en) | 1999-10-12 | 2003-05-06 | Hoffmann-La Roche Inc. | Substituted pyrroles suitable for continuous infusion |
| US6313143B1 (en) | 1999-12-16 | 2001-11-06 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| US6281356B1 (en) | 1999-12-22 | 2001-08-28 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| US6326501B1 (en) * | 2000-04-19 | 2001-12-04 | Hoffmann-La Roche Inc. | Methylation of indole compounds using dimethyl carbonate |
| US7129250B2 (en) * | 2000-05-19 | 2006-10-31 | Aegera Therapeutics Inc. | Neuroprotective and anti-proliferative compounds |
| CA2308994A1 (en) * | 2000-05-19 | 2001-11-19 | Aegera Therapeutics Inc. | Neuroprotective compounds |
| TW201041580A (en) | 2001-09-27 | 2010-12-01 | Alcon Inc | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| EP1441772A2 (de) * | 2001-10-29 | 2004-08-04 | Nektar Therapeutics Al, Corporation | Polymerkonjugate von protein-kinase-c-inhibitoren |
| CA2393720C (en) * | 2002-07-12 | 2010-09-14 | Eli Lilly And Company | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
| RU2547148C2 (ru) | 2005-02-09 | 2015-04-10 | Аркьюл, Инк. | Композиции и способы лечения рака |
| JP2010513386A (ja) * | 2006-12-19 | 2010-04-30 | ノバルティス アーゲー | キナーゼ阻害剤としてのインドリルマレイミド誘導体 |
| EP2173748B1 (de) | 2007-06-22 | 2011-08-31 | ArQule, Inc. | Indolylpyrrolidine zur behandlung von krebs |
| JP2010530885A (ja) | 2007-06-22 | 2010-09-16 | アークル インコーポレイテッド | キナゾリノン化合物およびその使用方法 |
| JP5425060B2 (ja) * | 2007-06-22 | 2014-02-26 | アークル インコーポレイテッド | ピロリジノン、ピロリジン−２，５−ジオン、ピロリジンおよびチオスクシンイミド誘導体、癌の治療のための組成物および方法 |
| GB201111427D0 (en) * | 2011-07-05 | 2011-08-17 | Amakem Nv | Novel bisindolylmaleimides, pan-pkc inhibitors |
| JP2017524739A (ja) | 2014-07-17 | 2017-08-31 | アンセルムＩｎｓｅｒｍ | 神経筋接合部関連疾患の処置方法 |
| WO2016207366A1 (en) | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of viral infections |
| CN105777751B (zh) * | 2016-04-26 | 2018-12-11 | 浙江工业大学 | 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用 |
| CN107973785B (zh) * | 2017-11-27 | 2019-12-31 | 浙江工业大学上虞研究院有限公司 | 一种用于检测银离子的荧光探针及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ227850A (en) * | 1988-02-10 | 1991-11-26 | Hoffmann La Roche | Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders |
| PT93947B (pt) * | 1989-05-05 | 1996-11-29 | Goedecke Ag | Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem |
| US5380746A (en) | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| JPH0539289A (ja) | 1991-02-15 | 1993-02-19 | Masahiro Irie | 無水マレイン酸誘導体およびその製造方法 |
| EP0630241A1 (de) | 1992-03-20 | 1994-12-28 | The Wellcome Foundation Limited | Indolderivate mit antiviraler wirkung |
| DE4217964A1 (de) | 1992-05-30 | 1993-12-02 | Goedecke Ag | Indolocarbazol-Imide und deren Verwendung |
-
1997
- 1997-07-15 PE PE1997000629A patent/PE91598A1/es not_active Application Discontinuation
- 1997-07-19 JP JP10508452A patent/JP2000516588A/ja not_active Ceased
- 1997-07-19 AU AU42963/97A patent/AU740011B2/en not_active Ceased
- 1997-07-19 WO PCT/EP1997/003888 patent/WO1998004551A1/en active IP Right Grant
- 1997-07-19 KR KR1019997000711A patent/KR20000029640A/ko active IP Right Grant
- 1997-07-19 DK DK97918934T patent/DK0915870T3/da active
- 1997-07-19 TR TR1999/00186T patent/TR199900186T2/xx unknown
- 1997-07-19 EP EP97918934A patent/EP0915870B1/de not_active Expired - Lifetime
- 1997-07-19 BR BR9711607A patent/BR9711607A/pt not_active IP Right Cessation
- 1997-07-19 AT AT97918934T patent/ATE224889T1/de not_active IP Right Cessation
- 1997-07-19 CA CA002262089A patent/CA2262089A1/en not_active Abandoned
- 1997-07-19 PT PT97918934T patent/PT915870E/pt unknown
- 1997-07-19 ES ES97918934T patent/ES2183163T3/es not_active Expired - Lifetime
- 1997-07-19 DE DE69715870T patent/DE69715870T2/de not_active Expired - Fee Related
- 1997-07-19 CN CN97196783A patent/CN1077571C/zh not_active Expired - Fee Related
- 1997-07-22 AR ARP970103308A patent/AR007969A1/es unknown
- 1997-07-25 HR HR60/048,496A patent/HRP970415A2/hr not_active Application Discontinuation
- 1997-07-25 CO CO97042636A patent/CO4900054A1/es unknown
- 1997-07-29 MA MA24743A patent/MA24354A1/fr unknown
-
1998
- 1998-12-22 US US09/218,404 patent/US6228877B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69715870D1 (de) | 2002-10-31 |
| CO4900054A1 (es) | 2000-03-27 |
| CN1077571C (zh) | 2002-01-09 |
| AR007969A1 (es) | 1999-11-24 |
| KR20000029640A (ko) | 2000-05-25 |
| EP0915870A1 (de) | 1999-05-19 |
| MA24354A1 (fr) | 1998-07-01 |
| CN1226248A (zh) | 1999-08-18 |
| DE69715870T2 (de) | 2003-06-18 |
| ES2183163T3 (es) | 2003-03-16 |
| PT915870E (pt) | 2003-01-31 |
| CA2262089A1 (en) | 1998-02-05 |
| DK0915870T3 (da) | 2003-02-03 |
| JP2000516588A (ja) | 2000-12-12 |
| US6228877B1 (en) | 2001-05-08 |
| BR9711607A (pt) | 1999-08-24 |
| EP0915870B1 (de) | 2002-09-25 |
| WO1998004551A1 (en) | 1998-02-05 |
| PE91598A1 (es) | 1998-12-24 |
| TR199900186T2 (xx) | 1999-03-22 |
| ATE224889T1 (de) | 2002-10-15 |
| AU4296397A (en) | 1998-02-20 |
| AU740011B2 (en) | 2001-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP970415A2 (en) | Substituted pyrroles | |
| HRP970414A2 (en) | Substituted pyrroles | |
| EP0328026B1 (de) | Substituierte Pyrrole | |
| EP0024852B1 (de) | 2,3-Dihydro-1H-indol-Derivate und Zwischenprodukte dafür, Verfahren zu ihrer Herstellung, diese Derivate enthaltende pharmazeutische Zusammensetzungen und ihre Herstellung | |
| US8598179B2 (en) | Pyrazole-carboxamide derivatives as P2Y12 antagonists | |
| EP2485728B1 (de) | Antagonisten des wnt-signalweges | |
| Bell et al. | 3-Substituted 1, 4-benzodiazepin-2-ones | |
| HU195220B (en) | Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them | |
| ITTO991009A1 (it) | Antagonisti iii del recettore ccr-3. | |
| US6143762A (en) | Tetrahydroisoquinoline derivatives and their pharmaceutical use | |
| KR100891439B1 (ko) | 치환된 벤즈이미다졸 화합물, 및 이를 포함하는 암 치료용 약제학적 조성물 | |
| KR20130120517A (ko) | 암을 치료하기 위한 hdac 억제제로서 4-아미노-n-하이드록시-벤즈아미드 | |
| EP0539057A1 (de) | Benzimidazol Phosphono-Aminosäure | |
| HRP970417A2 (en) | Substituted pyrroles | |
| CA2091688A1 (en) | Antiproliferative substituted naphthalene compounds | |
| USRE36736E (en) | Substituted pyrroles | |
| CN114478522B (zh) | 一种吡啶并咪唑类衍生物及其制备方法与应用 | |
| CA1117525A (en) | 2,3-polymethylene-4-oxo-4h-pyrido /1,2-a/ pyrimidines and process for the preparation thereof | |
| DE68910593T2 (de) | Chinolinoncarbonsäuren. | |
| HRP20020536A2 (en) | Substituted pyrroles | |
| MXPA99001027A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
| MXPA99000961A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
| MXPA99001026A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
| MXPA00008923A (en) | Substituted bisindolymaleimides for the inhibition of cell proliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ODBC | Application rejected |